Literature DB >> 11083778

Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni.

P Guerry1, C P Ewing, T E Hickey, M M Prendergast, A P Moran.   

Abstract

Three genes involved in biosynthesis of the lipooligosaccharide (LOS) core of Campylobacter jejuni MSC57360, the type strain of the HS:1 serotype, whose structure mimics GM(2) ganglioside, have been cloned and characterized. Mutation of genes encoding proteins with homology to a sialyl transferase (cstII) and a putative N-acetylmannosamine synthetase (neuC1), part of the biosynthetic pathway of N-acetylneuraminic acid (NeuNAc), have identical phenotypes. The LOS cores of these mutants display identical changes in electrophoretic mobility, loss of reactivity with cholera toxin (CT), and enhanced immunoreactivity with a hyperimmune polyclonal antiserum generated against whole cells of C. jejuni MSC57360. Loss of sialic acid in the core of the neuC1 mutant was confirmed by fast atom bombardment mass spectrometry. Mutation of a gene encoding a putative beta-1,4-N-acetylgalactosaminyltransferase (Cgt) resulted in LOS cores intermediate in electrophoretic mobility between that of wild type and the mutants lacking NeuNAc, loss of reactivity with CT, and a reduced immunoreactivity with hyperimmune antiserum. Chemical analyses confirmed the loss of N-acetylgalactosamine (GalNAc) and the presence of NeuNAc in the cgt mutant. These data suggest that the Cgt enzyme is capable of transferring GalNAc to an acceptor with or without NeuNAc and that the Cst enzyme is capable of transferring NeuNAc to an acceptor with or without GalNAc. A mutant with a nonsialylated LOS core is more sensitive to the bactericidal effects of human sera than the wild type or the mutant lacking GalNAc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083778      PMCID: PMC97763          DOI: 10.1128/IAI.68.12.6656-6662.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Sequence of the cloned Escherichia coli K1 CMP-N-acetylneuraminic acid synthetase gene.

Authors:  G Zapata; W F Vann; W Aaronson; M S Lewis; M Moos
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

2.  Antigenic variation of Campylobacter flagella.

Authors:  L A Harris; S M Logan; P Guerry; T J Trust
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

3.  Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors:  J Finne; M Leinonen; P H Mäkelä
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

4.  Campylobacter jejuni 81-176 associates with microtubules and dynein during invasion of human intestinal cells.

Authors:  L Hu; D J Kopecko
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.

Authors:  D H Figurski; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors.

Authors:  H Lior; D L Woodward; J A Edgar; L J Laroche; P Gill
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

7.  Activation of the classical and alternative pathways of complement by Treponema pallidum subsp. pallidum and Treponema vincentii.

Authors:  T J Fitzgerald
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

9.  Physiology of sialic acid capsular polysaccharide synthesis in serogroup B Neisseria meningitidis.

Authors:  L Masson; B E Holbein
Journal:  J Bacteriol       Date:  1983-05       Impact factor: 3.490

10.  Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.

Authors:  M J Blaser; P F Smith; P F Kohler
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

View more
  62 in total

1.  A deep-rough mutant of Campylobacter jejuni 81-176 is noninvasive for intestinal epithelial cells.

Authors:  Margaret I Kanipes; Lindsay C Holder; Adrian T Corcoran; Anthony P Moran; Patricia Guerry
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  A sigma28-regulated nonflagella gene contributes to virulence of Campylobacter jejuni 81-176.

Authors:  Scarlett Goon; Cheryl P Ewing; Maria Lorenzo; Dawn Pattarini; Gary Majam; Patricia Guerry
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 3.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

4.  Mutation of waaC, encoding heptosyltransferase I in Campylobacter jejuni 81-176, affects the structure of both lipooligosaccharide and capsular carbohydrate.

Authors:  Margaret I Kanipes; Erzsebet Papp-Szabo; Patricia Guerry; Mario A Monteiro
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

5.  Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.

Authors:  Frédéric Poly; Timothy D Read; Yu-Han Chen; Mario A Monteiro; Oralak Serichantalergs; Piyarat Pootong; Ladaporn Bodhidatta; Carl J Mason; David Rockabrand; Shahida Baqar; Chad K Porter; David Tribble; Michael Darsley; Patricia Guerry
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

6.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

7.  Campylobacter jejuni biofilms up-regulated in the absence of the stringent response utilize a calcofluor white-reactive polysaccharide.

Authors:  Meghan K McLennan; Danielle D Ringoir; Emilisa Frirdich; Sarah L Svensson; Derek H Wells; Harold Jarrell; Christine M Szymanski; Erin C Gaynor
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

8.  The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Authors:  Alexander C Maue; Krystle L Mohawk; David K Giles; Frédéric Poly; Cheryl P Ewing; Yuening Jiao; Ginyoung Lee; Zuchao Ma; Mario A Monteiro; Christina L Hill; Jason S Ferderber; Chad K Porter; M Stephen Trent; Patricia Guerry
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

9.  Genetic analysis of lipooligosaccharide core biosynthesis in Campylobacter jejuni 81-176.

Authors:  Margaret I Kanipes; Xuan Tan; Aurel Akelaitis; Jiajun Li; David Rockabrand; Patricia Guerry; Mario A Monteiro
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

10.  Campylobacter jejuni cocultured with epithelial cells reduces surface capsular polysaccharide expression.

Authors:  N Corcionivoschi; M Clyne; A Lyons; A Elmi; O Gundogdu; B W Wren; N Dorrell; A V Karlyshev; B Bourke
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.